Universal Electronics: Court Affirms Ruling Against Roku in Patent Dispute — Update
By Denny Jacob
Universal Electronics said a court affirmed a prior ruling by the U.S. International Trade Commission that banned the import and sale of streaming products by Roku that infringed on its patent.
The control and sensor technology solutions company said the ruling by the U.S. Court of Appeals for the Federal Circuit confirms that streaming-service provider Roku won't be able to import or sell any infringing products in the United States until its patent expires in 2032. It adds that its U.S. District Court cases against Roku and its TV partners were on hold until the decision was finalized, but the ruling now paves the way for it to return to U.S. District Court and collect monetary damages.
Universal Electronics said the ruling confirmed the International Trade Commission's findings that Roku's products infringe six different claims of the company's patent.
"Today's decision by the Federal Circuit upholding the ITC's final determination, which was issued in November 2021, has no impact on Roku or its customers," a Roku spokesperson said. "As part of its final determination, the ITC determined that Roku had successfully implemented technical design changes that eliminated any infringement of the one UEI patent that the ITC did not find to be invalid," the spokesperson added.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
January 19, 2024 16:14 ET (21:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel in Earnings Season
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth